Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 1/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | PLA2G2A | P14555 | 4/20 | 0.39 |
| ▸ | PLA2G4A | P47712 | 4/20 | 0.39 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.38 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 3/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.38 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.37 |
| ▸ | AHR | P35869 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MMP12 | P39900 | 1/20 | 0.37 |
| ▸ | MMP13 | P45452 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17945156 | 0.96 | HCRTR1 (0.44) | HCRTR1PGRPLA2G2APLA2G4ACASP3 | |
| SCHEMBL19109793 | 0.94 | HCRTR1 (0.39) | HCRTR1PGRPLA2G2APLA2G4ACASP3 | |
| SCHEMBL19109799 | 0.93 | HCRTR1 (0.42) | HCRTR1PGRPLA2G2APLA2G4ACASP3 | |
| SCHEMBL13506942 | 0.93 | PGR (0.42) | HCRTR1PGRPLA2G2APLA2G4AESR1 | |
| SCHEMBL17945135 | 0.93 | PGR (0.44) | HCRTR1PGRPLA2G2APLA2G4ACASP3 | |
| SCHEMBL13507287 | 0.93 | CYP1A1 (0.40) | HCRTR1PGRESR1ESR2AHR | |
| SCHEMBL19108504 | 0.93 | AHR (0.42) | HCRTR1PLA2G2APLA2G4APLA2G10AHR | |
| SCHEMBL17931971 | 0.92 | ABCG2 (0.46) | HCRTR1PGRESR1ESR2AHR | |
| SCHEMBL17264008 | 0.91 | HCRTR1 (0.47) | HCRTR1PGRPLA2G2APLA2G4ACASP3 | |
| SCHEMBL19109797 | 0.91 | HCRTR1 (0.39) | HCRTR1PGRPLA2G2APLA2G4ACASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170200905-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
| US-20170200905-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170200905-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNA1 | HCRTR1 200/4885PGR 1328/4885PLA2G2A 4537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.